Abstracts tagged "Activity score"

Abstract Number: 124 • 2012 ACR/ARHP Annual Meeting
Reliability of an Ultrasound Scoring Measure for Juvenile Localized Scleroderma (jLS)
Suzanne C. Li¹, Melissa S. Liebling², Andrea S. Doria³, Molly Dempsey-Robertson⁴, Carsten Hamer⁵, Sven Opitz⁵, Faridali Ramji⁶, Stephanie Edgerton⁶, Jose Jarrin³, Tanicka Kornyat², Michael Malone⁶, Arun Mohanta³, Shuzhen Zhang⁴ and Knut M. Wittkowski⁷, ¹Pediatrics, Joseph M Sanzari Children's Hospital, Hackensack University Medical Center, Hackensack, NJ, ²Radiology, Hackensack University Medical Center, Hackensack, NJ, ³Diagnostic Imaging, Hospital for Sick Children, Toronto, ON, Canada, ⁴Radiology, Texas Scottish Rite Hospital, Dallas, TX, ⁵Radiology, Schon Klinik Hamburg Eilbek, Hamburg, Germany, ⁶Radiology, University of OK Health Science Center, Okc, OK, ⁷Center for Clinical and Translational Science, Rockefeller University, New York, NY
Background/Purpose: Although ultrasound (US) shows great potential for aiding assessment of LS disease activity, its use has been limited because both image acquisition and interpretation…
Abstract Number: 1297 • 2012 ACR/ARHP Annual Meeting
Tofacitinib and Adalimumab Achieve Similar Rates of Low Disease Activity in Rheumatoid Arthritis — Lack of Improvement in Disease Activity Score by 3 Months Predicts Low Likelihood of Low Disease Activity At 1 Year
Ronald F. van Vollenhoven¹, Sriram Krishnaswami², Birgitta Benda³, David Gruben⁴, Bethanie Wilkinson⁴, Charles A. Mebus⁴, Samuel H. Zwillich² and John Bradley², ¹Karolinska Institute, Stockholm, Sweden, ²Pfizer Inc, Groton, CT, ³Pfizer Inc., Collegeville, PA, ⁴Pfizer Inc., Groton, CT
Background/Purpose: Tofacitinib is a novel oral Janus kinase inhibitor being investigated as a targeted immunomodulator and disease-modifying therapy for RA. This post-hoc analysis of the…
Abstract Number: 76 • 2012 ACR/ARHP Annual Meeting
The Difference in Performance of DAS28 and RADAI During Pregnancy Might Explain Discrepancies Between Older and More Recent Studies On the Impact of Pregnancy On Rheumatoid Arthritis
Jan Naterop¹, Johanna M.W. Hazes² and Radboud J.E.M. Dolhain³, ¹Rheumatology, Erasmus Medical Center, University Medical Center Rotterdam, Rotterdam, The Netherlands, Rotterdam, Netherlands, ²Rheumatology, Erasmus University Medical Center, Rotterdam, Netherlands, ³Rheumatology, Erasmus Medical Center, Rotterdam, Netherlands
Background/Purpose: Pregnancy is the only condition in which Rheumatoid Arthritis (RA) shows spontaneous remission. Both older and more recent studies showed improvement of disease activity,…
Abstract Number: 1232 • 2012 ACR/ARHP Annual Meeting
Association of Actometer Assessed Physical Activity and Fatigue in Patients with Rheumatoid Arthritis: Patients with a Lower Daily Activity Have More Fatigue
Sanne van Dartel¹, Han Repping-Wuts¹, Dewy van Hoogmoed¹, Hans Knoop², Gijs Bleijenberg¹, Piet L.C. van Riel³ and J. Fransen³, ¹Reumatology 470, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, ²Nijmegen Expert Centre of Chronic Fatigue, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, ³Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
Background/Purpose: Fatigue in rheumatoid arthritis (RA) is related to pain and disability, and several psycho-social factors such as coping strategies. In Chronic Fatigue Syndrome (CFS),…
Abstract Number: 77 • 2012 ACR/ARHP Annual Meeting
Comorbid Conditions Do Not Explain Divergent Patient Assessments of Disease Activity and Global Health in Patients with Rheumatoid Arthritis
Dörte Huscher¹, Katja Thiele², Sascha Bischoff², Ulrich von Hinüber³, Guido Hoese⁴, Kirsten Karberg⁵, Wolfgang Ochs⁶ and Angela Zink⁷, ¹German Rheumatism Research Centre and Charité University Medicine, Berlin, Germany, ²German Rheumatism Research Centre, Berlin, Germany, ³Rheumatologist in Private Practice, Hildesheim, Germany, ⁴Rheumatologist in Private Practice, Stadthagen, Germany, ⁵Rheumatologist in Private Practice, Berlin, Germany, ⁶Rheumatologist in Private Practice, Bayreuth, Germany, ⁷Epidemiology Unit, German Rheumatism Research Centre and Charité University Medicine, Berlin, Germany
Background/Purpose: In the discussion of the 2010 ACR/EULAR remission criteria the issue has been raised to what extent patients are able to distinguish rheumatoid arthritis…
Abstract Number: 1234 • 2012 ACR/ARHP Annual Meeting
Barriers, Benefits and Preferences for Exercise in RA Patients: A Cross Sectional Study
Yves Henchoz¹, Pascal Zufferey² and Alexander So³, ¹Département de chiropratique, Université du Québec à Trois-Rivières, Trois-Rivières, QC, Canada, ²Service of Rheumatology, Department of Musculoskeletal Medicine, Lausanne University Hospital, Lausanne, Switzerland, ³Rheumatology, CHUV, Univ of Lausanne, Lausanne, Switzerland
Background/Purpose: Physical exercise is safe and effective as an adjunctive nonpharmacological treatment modality in the management of rheumatoid arthritis (RA). It is well established that…
Abstract Number: 79 • 2012 ACR/ARHP Annual Meeting
Physician’s Global Assessment Is Affected by Physician’s Age and Gender, but Not by Patient Age and Gender in Rheumatoid Arthritis Patients Treated in Routine Care. Data From the Danish Nationwide Danbio Registry
Cecilie Lindstrom Egholm¹, Theodore Pincus², Lene Dreyer³, Torkell Ellingsen⁴, Bente Glintborg³, Marcin Kowalski⁵, Tove Lorenzen⁴, Ole Rintek Madsen⁶, Henrik Nordin⁷, Claus Rasmussen⁸ and Merete L. Hetland⁹, ¹Copenhagen University Hospital / DANBIO at Glostrup, Copenhagen, Denmark, ²Rheumatology, Rush University Medical Center, Chicago, IL, ³Copenhagen University Hospital at Gentofte, Gentofte, Denmark, ⁴Diagnostic Centre, Region Hospital Silkeborg, Silkeborg, Denmark, ⁵Aalborg University Hospital, Aalborg, Denmark, ⁶Dept. of Rheumatoglogy/C, Copenhagen University Hospital Gentofte, Hellerup, Denmark, ⁷Rigshospitalet, Copenhagen, Denmark, ⁸Vendsyssel Teaching Hospital/Aalborg University, Hjoerring, Denmark, ⁹Copenhagen University Hospital Glostrup, Copenhagen, Denmark
Background/Purpose: Several studies have shown that significant discordance exists between patient (PATGL) and physician (DOCGL) global measures of rheumatoid arthritis (RA) disease activity. These studies…
Abstract Number: 1158 • 2012 ACR/ARHP Annual Meeting
Development of Cut-off Values for High Disease Activity in Juvenile Idiopathic Arthritis Based On the Juvenile Arthritis Disease Activity Score
Alessandro Consolaro¹, Stefano Lanni¹, Sara Verazza¹, Maria C. Gallo¹, Marta Bertamino¹, Giulia C. Varnier¹, Serena Calandra², Nicolino Ruperto³, Alberto Martini⁴ and Angelo Ravelli⁵, ¹Pediatria II, Istituto Giannina Gaslini, Genova, Italy, ²University of Genova, Genova, Italy, ³Paediatric Rheumatology International Trials Organisation [PRINTO], Genova, Italy, ⁴Pediatric Rheumatology Collaborative Study Group [PRSCG], Cincinnati, OH, ⁵Paediatric Rheumatology International Trials Organization (PRINTO), Istituto Giannina Gaslini, Genova, Italy
Background/Purpose: In the last decade, there have been major advances in the management of juvenile idiopathic arthritis (JIA), including the shift towards early aggressive interventions…
Abstract Number: 2664 • 2012 ACR/ARHP Annual Meeting
A Multi-Biomarker Disease Activity (VECTRA™ DA Algorithm) Score Reflects Clinical Disease Activity and Tracks Responses in Patients with Rheumatoid Arthritis Treated with Either Adalimumab, Etanercept, and Infliximab
Shintaro Hirata¹, Douglas J. Haney², Guy Cavet², Rebecca Bolce², Wanying Li², Nadine Defranoux², David Chernoff², Kunihiro Yamaoka¹, Kazuyoshi Saito¹ and Yoshiya Tanaka¹, ¹The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, ²Crescendo Bioscience Inc., South San Francisco, CA
Background/Purpose : Anti-TNF therapy has become a standard therapeutic strategy for treatment of patients with rheumatoid arthritis (RA). A validated multi-biomarker disease activity algorithm (MBDA) blood…
Abstract Number: 1044 • 2012 ACR/ARHP Annual Meeting
Ultrasound Scores of Enthesitis and Dactylitis Do Not Correlate with Corresponding Clinical Findings in Psoriasis Arthritis
Rusmir Husic¹, Josef Hermann¹, Judith Gretler², Winfried B. Graninger³ and Christian Dejaco⁴, ¹Rheumatology, Medical University Graz, Graz, Austria, ²Med Univ Klinik Graz, Auenbruggerplatz 15, Graz, Austria, ³Internal medicine/Rheumatology and Immunology, Medical University Graz, Graz, Austria, ⁴Rheumatology, Southend University Hospital, Westcliff-on-Sea, United Kingdom
Background/Purpose: To compare sonography verified inflammation of entheses, tendons and joints with corresponding clinical findings in psoriasis arthritis (PsA) patients. Methods: Prospective study of 70 consecutive…
Abstract Number: 691 • 2012 ACR/ARHP Annual Meeting
Characterization of Pro-Inflammatory Cytokines and Vitamin D Levels in a Lupus Cohort and Correlation with Disease Activity
Rohan Willis¹, Praveen Jajoria¹, Brock E. Harper², Emilio B. Gonzalez³, Michelle Petri⁴, Ehtisham Akhter⁵, Hong Fang⁴ and Silvia S. Pierangeli¹, ¹Rheumatology/Dept Int Med, University of Texas Medical Branch, Galveston, TX, ²Int Med/Rheumatology, University of Texas Medical Branch, Galveston, TX, ³Rheumatolgoy/Dept Int Med, University of Texas Medical Branch, Galveston, TX, ⁴Johns Hopkins University School of Medicine, Baltimore, MD, ⁵Div of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD
Background/Purpose: Multiple cytokines play a role in the immune dysregulation seen in systemic lupus erythematosus (SLE) and the local inflammatory responses that ultimately lead to…
Abstract Number: 563 • 2012 ACR/ARHP Annual Meeting
In Ankylosing Spondylitis, a Decrease in MRI Spinal Inflammation Predicts Improvement in Spinal Mobility Independently of Patient Reported Symptomatic Improvement
Pedro Machado¹, Robert Landewé², Jürgen Braun³, Xenofon Baraliakos⁴, Kay-Geert A. Hermann⁵, Benjamin Hsu⁶, Daniel Baker⁷ and Désirée van der Heijde¹, ¹Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ²Clinical Immunology & Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center, Heerlen, Netherlands, ³PsAID taskforce, EULAR, Zurich, Switzerland, ⁴Rheumatology, Rheumazentrum Ruhrgebiet, Herne, Germany, ⁵Radiology, Charité Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany, ⁶Janssen Research & Development, LLC., Spring House, PA, ⁷Research and Development, Centocor Inc., Malvern/Philadelphia, PA
Background/Purpose: It has been previously shown that spinal mobility in ankylosing spondylitis (AS) is associated with the level of inflammation of the spine. However an…
Abstract Number: 546 • 2012 ACR/ARHP Annual Meeting
The Immunogenicity to the First Anti-TNF Therapy Determines the Outcome of Switching to a Second Anti-TNF in Spondyloarthritis Patients
Chamaida Plasencia¹, Dora Pascual-Salcedo², Sara Garcia-Carazo³, Gema Bonilla⁴, Leticia Lojo⁵, Laura Nuño⁶, Alejandro Villalba⁷, Diana Peiteado⁷, Concepcion Castillo-Gallego⁷, Florencia Arribas², Daniel Nagore⁸, E. Martin-Mola⁹ and Alejandro Balsa⁴, ¹Rheumatology, Hospital La Paz-IdiPaz, Madrid, Spain, ²Immunology, Hospital La Paz. IdiPaz, Madrid, Spain, ³La PAZ University Hospital, RHEUMATOLOGY UNIT, Spain, Spain, ⁴Rheumatology, Hospital La Paz, Madrid, Spain, ⁵Rheumatology, Hospital Universitario La Paz, Spain, Spain, ⁶Hospital La Paz-IdiPaz, Madrid, Spain, ⁷Rheumatology, Hospital La Paz - IdiPaz, Madrid, Spain, ⁸Proteomika S.L., ⁹Servicio de Reumatología, Hospital Universitario La Paz, Madrid, Spain
Background/Purpose: Spondyloarthropathies (SpAs) encompass a heterogeneous group of diseases that primarily affect the axial skeleton and entheses. Although anti-TNF drugs have proven to be effective…
Abstract Number: 421 • 2012 ACR/ARHP Annual Meeting
Rheumatoid Factor, Not Antibodies to Citrullinated Proteins, Are Associated with High Disease Activity
Josef S. Smolen¹, Farideh Alasti² and Daniel Aletaha³, ¹Medical University of Vienna and Hietzing Hospital, Vienna, Austria, ²Department of Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, ³Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria
Background/Purpose: Autoantibodies in general, and rheumatoid factor (RF) and anti-citrullinated peptide antibodies (ACPA) in particular, are a hallmark of RA. After their characterization, ACPA have…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.